JAM
ACAD icon

Jupiter Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Jupiter Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Sell
458,466
-32,627
-7% -$718K 0.06% 287
2026
Q1 		$10.9M Sell
491,093
-129,956
-21% -$3.11M 0.06% 271
2025
Q4 		$16.6M Buy
621,049
+144,732
+30% +$3.46M 0.13% 180
2025
Q3 		$10.2M Sell
476,317
-160,058
-25% -$3.79M 0.09% 222
2025
Q2 		$13.7M Buy
636,375
+229,324
+56% +$4.26M 0.11% 206
2025
Q1 		$6.76M Buy
+407,051
New +$7.39M 0.06% 254
2024
Q4 		– Sell
-157,457
Closed -$2.42M – 384
2024
Q3 		$2.42M Sell
157,457
-903,383
-85% -$15.1M 0.02% 313
2024
Q2 		$17.2M Sell
1,060,840
-542,934
-34% -$8.76M 0.16% 175
2024
Q1 		$29.7M Buy
1,603,774
+281,410
+21% +$6.97M 0.28% 119
2023
Q4 		$41.4M Buy
1,322,364
+46,148
+4% +$1.1M 0.41% 69
2023
Q3 		$26.6M Buy
1,276,216
+4,932
+0.4% +$134K 0.29% 99
2023
Q2 		$30.4M Sell
1,271,284
-96,317
-7% -$2.14M 0.33% 82
2023
Q1 		$25.7M Buy
1,367,601
+277,629
+25% +$5.29M 0.36% 91
2022
Q4 		$17.3M Buy
1,089,972
+1,012,680
+1,310% +$15.8M 0.25% 129
2022
Q3 		$1.26M Buy
77,292
+12,273
+19% +$199K 0.02% 381
2022
Q2 		$917K Buy
+65,019
New +$1.21M 0.01% 440
2020
Q4 		– Sell
-116,258
Closed -$4.8M – 578
2020
Q3 		$4.8M Buy
+116,258
New +$5.02M 0.05% 304

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jupiter Asset Management's ACAD Position: Q2 2026 in Review

Jupiter Asset Management reduced its Acadia Pharmaceuticals (ACAD) stake by 6.6% in Q2 2026, selling an estimated $718K and leaving 458,466 shares worth $11.6M. The position accounts for 0.06% of the portfolio, ranked #287.

Jupiter Asset Management first reported a position in ACAD in Q3 2020 and has held it in 17 quarters since. The position peaked at $41.4M in Q4 2023. 352 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Jupiter Asset Management held 458,466 shares of Acadia Pharmaceuticals worth $11.6M as of Q2 2026.
  • Jupiter Asset Management sold 32,627 Acadia Pharmaceuticals shares in Q2 2026, an estimated $718K.
  • Acadia Pharmaceuticals made up 0.06% of Jupiter Asset Management's portfolio in Q2 2026, its #287 holding.
  • Jupiter Asset Management first reported a position in Acadia Pharmaceuticals in Q3 2020 and has held it in 17 quarters since.
  • Jupiter Asset Management's Acadia Pharmaceuticals position peaked at $41.4M in Q4 2023.
  • 352 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.